Eris Lifesciences Q4 Results
- BSE: 540596
- NSE: ERIS
- ISIN: INE406M01024
- Sector: Biotechnology & Drugs
BSE
1,327.55
0.55 (0.04%)
0.55 (0.04%)Volume2.84 K
Updated: Mon 7 Sep, 2026 | 15:27:33
NSE
1,324.302.60 (0.20%)
2.60 (0.20%)Volume27.44 K
Updated: Mon 7 Sep, 2026 | 15:52:04
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Eris Lifesciences Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 552.55 | 613.42 | -9.92% | 456.39 | 4.11% |
| Depreciation/ Amortization | 69.57 | 70.34 | -1.09% | 53.90 | -10.62% |
| Operating Income | 204.01 | 194.03 | 5.14% | 94.53 | 16.88% |
| Net Income | 281.62 | 99.72 | 182.41% | 70.96 | 201.36% |
| Other Operating Expenses Total | 160.88 | 164.46 | -2.18% | 181.83 | -0.20% |
| Net Income Before Taxes | 159.42 | 145.35 | 9.68% | 76.65 | 24.28% |
| Total Revenue | 756.56 | 807.45 | -6.30% | 550.93 | 7.27% |
| Selling/ General/ Admin Expenses Total | 136.85 | 138.08 | -0.89% | 102.48 | 12.68% |
| Diluted Normalized EPS | 20.37 | 8.26 | 146.72% | 5.21 | 197.16% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.